Angle Share Discussion Threads

[gspanner] 17/1/2024 08:37

Well Happy with another lot at 18p. Still crazily undervalued like so much AIM.

[bones699] 17/1/2024 08:23

Nobby.

So why no financials slides in the Investor Meet with a slide on forecasted revenues, earnings, expected breakeven, and cash runway then?

Answer Newland has no confidence in them and doesn't want to be held to account when later in the year they don't get delivered..

Some Investor Meet without any financials to judge the investment case!

Might as well just chuck a coin in the air!

And how much retail investors money have AGL burnt through in the years trading to date £200m is it?

[john henry] 17/1/2024 08:22

Gap to be filled at 14p taking out the recent news.

[bones699] 17/1/2024 08:21

Dave is too busy trying to ban people so he can ramp nonsense all day long!

[dave4545] 17/1/2024 08:11

So 22p paid 2 days ago for size and now the sheep are selling close to 18p bid

I'll be adding

[zeus19] 17/1/2024 00:03

Don't waste your time on people with small IQ's

[nobbygnome] 16/1/2024 21:20

The CFO clearly stated in a public forum that they could get through to breakeven without a cash raise so it is definitely not inevitable there will be one. That’s the reality and the continual talk about an imminent fund raise by the trolls is just a disgrace!

[bones699] 16/1/2024 20:23

No commercial deals means very simply a retracing of the share price..That RNS was simply there to prep the ground for a cash raise!..so was the Investor Meet hence no financials presented to judge the investment case!

[bones699] 16/1/2024 20:20

You lot are just so deluded its embarrassing to watch!

[5oletrader] 16/1/2024 20:07

On the Hunt!
Maybe? Just maybe?
-
-
-
- 2m 50s interesting - “We want to find SOLUTIONs to the BIG questions of the future - such as CANCER SCREENING”
-
In the words of Mark Douglas:
- ANYTHING can HAPPEN!

[reidy66] 16/1/2024 16:53

The gap never got filled mate as lower down @14p Pj

[john henry] 16/1/2024 16:10

PA looks like filling the gap down to 14p

[dave4545] 16/1/2024 15:39

2 bid they have sucked up a lot of sales today possible order filling for a fund at these lower prices

[5oletrader] 16/1/2024 13:04

If anyone is interested - update on my last:• RBC lists Antibody-Drug-Conjugates (ADCs) as BILLION category by 2030• NOTE approx 28s inhttps://www.cnbc.com/video/2023/10/23/rbc-lists-antibody-drug-conjugates-adcs-as-30-billion-category-by-2030.html-• Takeaway from the JPMorgan Healthcare Conference in San Francisco, the nation's largest gathering of biotech and pharmaceutical executives, analysts and investors. https://www.jpmorgan.com/about-us/events-conferences/health-care-conference• During the 4 day event, the biotech and pharmaceutical industry SIGNALED its enthusiasm for antibody-drug conjugates, or ADCs, which deliver a cancer-killing therapy to SPECIFICALLY TARGET and kill cancer cells and minimize damage to healthy ones.-• "It's kind of like FOMO, right? Everyone wants to gain exposure to ADCs basically make it a cornerstone of their entire corporate strategy," - "I really don't see any sort of slowing down and it will very much, in our view, be a CONTINUATION of the 2023 MOMENTUM." https://www.cnbc.com/amp/2024/01/14/cancer-drugs-renewed-interest-in-adcs-will-continue-in-2024.html• INTERESTING- Graybosch also noted that companies from JAPAN and China have emerged as effective ADC developers that are rapidly "innovating tweaks" to the drugs and bringing ADCs to the market that could be better than older versions of the drugs.• AGL involved with someone from JAPAN?-ATB

[luckyswimmer] 16/1/2024 13:00

Sorry to hear your news MrK. Hoping Parsortix or other non invasive tests become available soon.to help you and many others.

[boris cobaka] 16/1/2024 11:20

Morning.
Another shakedown attempt this morning but volume pretty poor. Bit of a stalemate at the MO. Good to have a bit of a breather.

[dave4545] 16/1/2024 10:00

I can just picture a market makers saying "buy"...like Eddie Murphy was when he was closing out his short for a massive profit with the mm having sold big size at 22p yesterday now buying back for 18.7p

this game eh...nobody can work together and make things hard for the mm's

[dave4545] 16/1/2024 08:15

Noticing the sales this morning are people who bought yesterday, they see something else today moving and sell their trade here for a loss to play elsewhere.

Low volume shaking on L2 so a drop followed by a rally later for me

[pj84] 16/1/2024 00:06

Looking forward to watching the video of the Proactive investors event tomorrow and the answers regarding the financial position.

[havinthelasttoast] 16/1/2024 00:04

Sure you did Bwana. Sure you did x

You lying rat. Hasn’t been near 1.40 when you were posting. The peak was 1.17 ya daft old senile mug.

[arthur_lame_stocks] 15/1/2024 23:45

"Oh no. Banana Bwana is back.

Biggest charting mug the world ever seen."

I was sure this time he was the perfect cup and handle.

[5oletrader] 15/1/2024 20:55

Re AGL Contract announcement with Eisai Inc. Again pondering the significance? ADCs:-The antibody-drug conjugate (ADC) market is picking up right where it left off in 2023 as ROCHE has made a potential $1 BILLION deal with China-based MediLink Therapeutics to develop a next-generation ADC in oncology.https://www.biospace.com/article/roche-signs-potential-1b-adc-deal-with-china-s-medilink/#:~:text=In%20October%202023%2C%20MediLink%20announced,Epidermal%20Growth%20Factor%20Receptor%203.What I found interesting:• ROCHE will be solely responsible for developing and commercializing the treatment globally.-What I found more interesting.• If I run the name Joseph Eid (as MrK alluded to) I notice this.• His previous experience includes senior positions in CLINICAL DEVELOPMENT and medical affairs at Bristol Myers Squibb, Merck & Co. and Hoffman-La ROCHE.https://angleplc.com/team/joseph-eid/-Re above ROCHE deal. MediLink will work with Roche's China Innovation Center to push the candidate into Phase I clinical trials.• Phase I trials - still a lot of work still be done.A way in with Mr Eid? Could AGL assist?https://www.pharmaceutical-technology.com/news/medilink-roche-cancer-drug/?cf-view-Final Thought - it highlights the kind of money involved. It's a multi BILLION dollar industry. With only 14 ADCs approved by FDA for clinical use and MORE than 100 ADCs in clinical trial - AGL have large open opportunities to tout for business (all in the ADC space alone).https://www.sciencedirect.com/science/article/pii/S0753332223001968#:~:text=Inspite%20of%20the%20fact%2C%20that,solid%20tumors%20(Table%201).-Food for thought?